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Abstract:  Geoditin  A,  an  isomalabaricane  triterpene  isolated  from  the  marine  sponge 
Geodia japonica, has been demonstrated to dissipate mitochondrial membrane potential, 
activate caspase 3, decrease cytoplasmic proliferating cell nuclear antigen (PCNA), and 
induce apoptosis of leukemia cells, but the underlying mechanism remains unclear [1]. In 
this study, we found fragmentation of Golgi structure, suppression of transferrin receptor 
expression, production of oxidants, and DNA fragmentation in human colon cancer HT29 
cells  after  treatment  with  geoditin  A  for  24  h.  This  apoptosis  was  not  abrogated  by 
chelation  of  intracellular  iron  with  salicylaldehyde  isonicotinoyl  hydrazone  (SIH),  but 
suppressed by N-acetylcysteine (NAC), a thiol antioxidant and GSH precursor, indicating 
that the cytotoxic effect of geoditin A is likely mediated by a NAC-inhibitable oxidative 
stress.  Our  results  provide  a  better  understanding  of  the  apoptotic  properties  and 
chemotherapeutical potential of this marine triterpene. 
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1. Introduction  
Colorectal cancer has traditionally been one of the four leading death cancers worldwide, but the 
incidence was relatively low in Asian populations. However, the prevalence of colorectal neoplasm 
has increased by 2- to 4-fold in some developed Asian countries, including China, Japan, South Korea, 
and Singapore in the past few decades [2], due to changes in dietary habits and lifestyle as well as 
certain genetic factors of Asian populations [2]. In Hong Kong there were 3,918 new bowel cancer 
cases and 1,628 deaths registered in 2006 [3], making colorectal cancer the second most common 
cancer and it is expected to surpass lung cancer to become the most common cancer within the next 
five years [3]. Surgical resection and chemotherapy are two common treatment strategies for early 
stage  colon  cancer,  but  recurrence  from  chemo-resistance  or  adverse  side  effects  of  conventional 
chemotherapeutic  agents,  such  as  cytotoxicity  of  5-fluorouracil,  not  only  hamper  the  therapeutic 
regimen but also affect the quality of life of the patients, therefore novel bioactive agents from natural 
sources are urgently needed for effective chemotherapy [4]. 
The  search  for  therapeutic  agents  or  bioactive  natural  compounds  from  territorial  plants  and 
microbes had a long tradition up to the initiation of the symposium “Drugs from the Sea” in 1968 [5], 
and since then over 16,000 different natural products have been isolated from marine organisms in the 
past decades [6]. These marine compounds are diverse in chemical structures and biological activities, 
and ziconotide (Prialt
®), a peptide from a tropical cone snail for the treatment of pain, was approved in 
the United States in 2004 [7], and trabectedin (Yonledis
®) from the Caribbean tunicate Ecteinascidia 
turbinata  was  approved  in  the  European  Union  in  2007  for  treatment  of  ovarian  cancer  [8]. 
Isomalabaricanes, tricyclic terpenoids isolated from many genera of marine sponges, have received 
special pharmaceutical attention because of their inhibitory activities towards the cyclin-dependent 
kinases and controlling tumor cell cycle proliferation, implicating the potential application of marine 
compounds for chemotherapy [8,9].  
Iron is an essential element to the body acting as a cofactor of heme proteins for a wide variety of 
cellular  processes  such  as  metabolism,  respiration,  and  DNA  synthesis.  It  forms  a  complex  with 
transferrin before they are delivered into the cells via interactions with surface transferrin receptor 
(TfnR)[10].  TfnR  is  constitutively  expressed  in  cancer  cells,  up  to  4-  to  5-fold  higher  than 
nonneoplastic cells because of the need for iron as a cofactor of DNA synthesis of rapidly dividing 
cells. Once the iron is released from the Tfn, the Tfn-TfnR complex is recycled either directly or 
indirectly through the Golgi complex back to the cell surface [10]. Abnormal expression of Tfn/TfnR 
results in an unbalanced iron homeostasis that is associated with oxidative stress and programmed cell 
death [10] which has been well documented in HT29 cells treated with flavone [11], or tangutorine 
[12]. In this study an apoptosis associated with a decrease of transferrin receptors and oxidative stress 
were  induced  by  geoditin  A  in  colon  cancer  HT29  cells,  and  this  apoptosis  was  diminished  by  
pre-treatment with oxidant scavenger, N-acetylcysteine, implicating the apoptosis inducing activity of 
geoditin A is mediated through oxidative stress. 
2. Results and Discussion 
Geoditin A (Figure 1) is an isomalabaricane triterpene with three sets of -unsaturated ketone 
structures, first isolated from Stelletta tenuis [13], but also extracted from a marine sponge, Geodia Mar. Drugs 2010, 8                       
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japonica, collected from South China Sea [14]. There is increasing evidence that isomalabaricane is a 
rare class of triterpenoids with potent tumor inhibitory activities [15,16], the values of IC50 for cancer 
cell  lines  ranging  from  0.1–20  µ g/mL,  which  has  brought  attention  to  its  potential  for 
chemotherapeutic development [17].  
Figure 1. Chemical structure of geoditin A. 
O
O
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Our  previous  study  has  also  demonstrated  a  potent  cytotoxicity  of  geoditin  A  against  human 
leukemia HL60 cells (IC50  3 µ g/mL), in which a dissipation of mitochondrial membrane potential, 
activation of caspase 3, and decrease of cytoplasmic proliferating cell nuclear antigen (PCNA) were 
revealed by fluorescence microscopy [1].  
Figure  2.  Cytotoxicity and apoptotic activity of geoditin A on HT29 cells and human 
dermal fibroblasts. Cells were incubated in 96-well plates with serial concentrations of 
geoditin A for 24 h, and its cytotoxicity was assessed by MTT bioassay (a). Results were 
presented as mean and standard deviation of triplicates. Treated cells were fixed in cold 
70% alcohol and stained with propidium iodide before the subG1 population (apoptosis) 
was measured by flow cytometry (b). 
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The treated cells also manifested nuclear fragmentation typical for apoptosis, but autophagic change 
was  not  prominent  although  compounds  with  -unsaturated  ketone  framework  may  induce 
autophagy [18], and the underlying mechanisms mediating these changes remain unclear. Geoditin A 
showed a dose-dependent cytotoxicity in human colon HT29 cells as determined by the MTT bioassay, 
and the value of IC50 is 20 μg/mL, which is at least 2 folds higher than that (IC50 = 60 μg/mL) for 
human dermal fibroblasts (Figure 2a), indicating its specificity for cancer cells. Increase of apoptosis 
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from 10% to 40% was measured in HT29 cells treated for 24h with geoditin A from 5 to 40 µ g/mL by 
flow cytometry (Figure 2b).  
Features for apoptosis, including nuclear fragmentation by DAPI staining, and Golgi fragmentation 
by immunofluorescence with antibody against golgin-97, a marker protein for the Golgi complex [19] 
were visualized in treated HT29 cells with a confocal microscope (Figure 3).  
Figure  3.  Golgi  fragmentation  in  apoptotic  HT29  cells.  Cells  were  treated  with  serial 
concentrations of geoditin A for 24 h, fixed in 3% paraformaldehyde (PFA) and incubated 
with  antibody  against  Golgi  marker  protein,  golgin-97  and  visualized  by  secondary 
antibody IgG conjugated to Alexa-647. Nuclei were counterstained with DAPI. Typical 
Golgi stack is shown at the juxtanuclear region of the untreated HT29 cells (a), while Golgi 
fragmentation becomes prominent in geoditin A-treated in a dose-dependent manner (b, c, 
and d for 10, 20 and 40 μg/mL, respectively). 
   
 
   
 
The  Golgi  apparatus  is  not  only  a  vital  organelle  for  protein  synthesis  and  post-translational 
modification, but can also regulate early apoptotic events [20]. The Golgi proteins, e.g., golgin-160 
and p115, are disassembled into fragments by proteolytic action of upstream caspases and followed by 
the nuclear translocation of the C-terminal fragment of p115 for an induction of apoptosis. It will be 
interesting to further study if a similar cell death pathway is shared by geoditin A. Flow cytometric 
analysis further confirmed an elevated subG1 population from 20% to 40% after treatment of HT29 
cells  for  20  µ g/mL  and  40  µ g/mL  geoditin  A,  respectively  (Figure  2b).  The  increase  of  subG1 
population mainly with the expense of G2/M cells implicated a decrease of cell growth by geoditin A 
treatment (Figure 4).  
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Figure 4. Change of DNA patterns in geoditin A-treated HT29 cells. Treated cells were 
fixed in cold 70% alcohol and stained with propidium iodide before their DNA patterns 
were analyzed by flow cytometry. SubG1 cell population increased in the expenses of 
G2/M populations. 
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Iron is an essential element for normal cell growth and metabolism, but a higher level of iron is 
required by malignant cells for their proliferation and progression. The increase of cellular iron uptake 
is associated with an increased expression of iron import proteins, such as Tfn and TfnR [21]. Iron in 
the serum is coupled to Tfn before endocytosis into the cell via interaction with its ligand receptors on 
the plasma membrane, and iron is then released from the Tfn-TfnR complex in the endosomes before 
both Tfn and TfnR are returned to the plasma membrane through recycling endosomes [11].  
Figure 5. Suppression of Tfn endocytosis by geoditin A. HT29 cells were treated with 
geoditin A for 24 h, washed with warm plain DMEM medium with 1% BSA, incubated 
with fresh DMEM containing 50 µ g/mL Alexa-594 Tfn for 60 min, before the cellular 
uptake of Tfn was observed under a fluorescence microscope. Representative images were 
captured using FV1600 Olympus system. Tfn was located in endosomes of untreated cells 
(a) but decreased in a dose-dependent manner after treatment with geoditin A for 24 h (b, 
c, d for 10, 20 and 40 µ g/mL, respectively). About 30% decrease of Alexa-594 Tfn was 
measured in HT29 cells treated with geoditin A for 40 µ g/mL by flow cytometry (e). 
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Figure 5. Cont. 
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TfnR is up-regulated in cancer cells for enhancing iron uptake, and iron depletion by iron chelators 
or decreased expression of Tfn and TfnR have been proven to be effective in the treatment of cancer 
[10,21]. Tfn endocytosed into HT29 cells and accumulated in the early/late and recycling endosomes 
in  the  cytoplasm  (Figure  5a),  but  the  level  of  endocytic  Tfn-fluorescence  decreased  in  a  
dose-dependent manner in geoditin A-treated cells (Figures 5b-d), and a decrease of >30% labeled 
transferrin  in  these  cells  was  measured  by  flow  cytometric  analysis  (Figure  5e).  Immunoblotting 
analysis also showed a significant down-regulation of iron carriers, TfnR, in HT29 cells after treatment 
with geoditin A for 24 h, particularly at ≥20 µ g/mL (Figure 6). 
Figure 6. Down-regulation of transferrin receptor (TfnR) expression in geoditin A-treated 
HT29  cells.  Treated  HT29  cells  were  lysed  and  total  protein  lysate  was  subjected  to 
separation on a 10% SDS-PAGE gel, transferred onto a PVDF membrane and probed with 
antibodies against TfnR and β-actin. 
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Reactive oxygen species (ROS) are by-products of aerobic metabolism which play important role in 
intracellular  signaling  cascades.  Mitochondria  and  NADPH  oxidase  are  two  major  sources  for 
c  d 
e 
Actin 
Geoditin A (μg/ml) 
TfnR Mar. Drugs 2010, 8                       
 
 
86 
intracellular  ROS  whose  overproduction  can  activate  stress  pathway  that  ultimately  leads  to  cell 
apoptosis  [22].  Intracellular  iron  is  also  a  pro-oxidant  catalyst  which  induces  oxidative  stress  via 
Fenton/Haber-Weiss  reaction  [23],  DNA  strand  breakage  and  cell  death  [24].  Iron  chelators,  e.g., 
salicylaldehyde isonicotinoyl hydrazone (SIH), binds intracellular labile iron, reduces iron-catalyzed 
hydroxyl  radical  generation,  and  thus  protects  cells  from  apoptosis  [25].  In  order  to  delineate  if 
apoptotic changes of HT29 cells in this study was mediated by oxidative stress or iron overload, cells 
were  intervened  with  antioxidants  or  iron  chelators  before  apoptosis  was  induced  by  20  µ g/mL 
geoditin A for 24 h.  
Results of flow cytometry with these cells show that 20% of HT29 cells had undergone apoptosis 
which  could  not  be  rescued  by  oxidant  inhibitors,  e.g.,  diphenyleneiodonium  chloride (DPI)  and 
rotenone for NADPH oxidase and electron transport in complex I of mitochondria, respectively (data 
not shown), or iron chelation with 5 μM SIH, but pre-treatment of 10 mM N-acetylcysteine (NAC) 
could reduce apoptosis by more than 60% (Figure 7), implicating a major role of oxidative stress in an 
induction of apoptotic changes in HT29 cells. Taken our results together, we have demonstrated that 
geoditin  A  induced  oxidative  stress  in  HT29  cells  and  elicited  its  cytotoxicity  through  a  
N-acetylcysteine inhibitable apoptosis.  
Figure 7. Suppression of HT29 apoptosis by oxidant scavenger NAC. HT29 cells were 
pre-incubated  with  oxidant  inhibitors,  NAC  (N-acetylcysteine,  10  mM), 
diphenyleneiodonium chloride (DPI, 1 µ M) and rotenone (ROT, 5 µ M), or iron chelator 
SIH (5 μM) for 2 h and further co-cultured for 24 h with 20 μg/mL geoditin A before their 
apoptosis  cells  were  measured  by  flow  cytometry.  Treatment  of  cells  with  oxidative 
inhibitors  or  SIH  alone  did  not  show  significant  differences  with  untreated  control. 
Treatment of geoditin A-treated cells with NAC significantly reduced apoptosis from 19% 
to only 5.5%, whereas DPI (18%), Rot (18.7%), and SIH (16.4%) pre-treatment could not 
protect cells from apoptosis (19% for cells treated with geoditin A). Cells without geoditin 
A  treatment  served  as  controls  (CTL).  Results  were  presented  as  mean  and  standard 
deviation of triplicates. 
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3. Experimental Section  
3.1. Test compounds  
Geoditin A is an isomalabaricane triterpene isolated from a marine sponge, Geodia japonica [14], 
and it has a molecular weight of 450 and a molecular formula of C20H26O4 as determined by mass 
spectrometry and elemental analysis [14]. The compound was dissolved in DMSO to make a stock 
solution at a concentration of 40 mg/mL which was then diluted to appropriate concentrations with 
culture medium before each experiment. The final concentration of DMSO did not exceed 0.5% in any 
experiment. Iron chelator, salicylaldehyde isonicotinoyl hydrazone, was a kind gift of Dr. P Ponka of 
Jewish General Hospital, Montreal, Canada. 
3.2. Cell cultures 
Human colon cancer HT29 (HTB-38, ATCC) cells and human dermal fibroblasts were routinely 
maintained  in  RPMI-1640  and  DMEM,  respectively,  supplemented  with  10%  fetal  bovine  serum 
(FBS), 100 g/mL streptomycin and 100 IU/mL penicillin at 37C in a humidified atmosphere of  
5% CO2. 
3.3. Cell proliferation assay 
HT29 cells and dermal fibroblasts (2 x 10
4 cells/ 0.1 mL / well) were treated with a serial dilution of 
geoditin A in 96-well culture plates (Costar, USA) or 8-chamber culture slides (Nunc 177402, USA) 
for 48 h. During the last 4 h, cells were reacted with MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl 
tetrazolium bromide) at 37 C for colorimetric MTT-based cytotoxicity assay. The reaction product, 
formazan, was extracted with DMSO and the absorbance was read at 540 nm [12]. Data represent the 
mean values and standard deviations of triplicate assays in at least one experiment.  
3.4. Fluorescence staining for morphological observation  
HT29 cells were treated with a serial dilution of geoditin A in 8-chamber slides for 24 h, washed 
briefly with phosphate-buffered saline (PBS) before they were fixed with buffered formalin, stained 
with antibody against golgin-97 (A21270, Invitrogen, USA), a marker for Golgi complex, followed by 
secondary antibody IgG conjugated to Alexa-647 in TBS-T buffer, and the chromatin was counter-
stained  with  DAPI  before  the  slides  were  mounted  with  anti-fade  for  microscopy  on  a  confocal 
microscope (Axioskop, Zeiss, Japan) with a 450–490 nm excitation block filter and a 520 nm barrier 
filter [12].  
3.5. Flow cytometric cell cycle analysis 
Cells were treated with geoditin A for 24 h and a cell suspension of 100,000 cells was fixed with 
70% alcohol for 15 min at 4 C, treated with RNase A and stained with 1.0 g/mL propidium iodide 
(PI, Boehringer Mannheim, Germany). The red fluorescence of DNA-bound PI in individual cells was 
measured at 488 nm with a Beckman Coulter Altra flow cytometer and the results were analyzed using 
Expo32  software  (Beckman  Coulter,  USA)[12].  Cells  pre-incubated  with  diphenyleneiodonium Mar. Drugs 2010, 8                       
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chloride  (DPI,  1  µ M),  rotenone  (ROT,  5  µ M),  NAC  (10  mM),  or  SIH  (5  µ M)  for  2  h  before  
co-cultured with 20 µ g/mL geoditin A for 24 h were subjected to apoptosis analysis by flow cytometry 
to elucidate the source of ROS production [12], and the effect of intracellular iron. 
3.6. Immunoblotting analysis 
HT29 cells at 24 h after 2h-drug exposure were washed with PBS twice, and the total protein 
lysates were obtained in lysis buffer (50 mM Tris-Cl, 150 mM NaCl, 0.2% Triton X-100, 10 µ g/mL 
aprotinin  and  0.5  mM  PMSF),  and  centrifuged  at  10000  rpm  at  4  º C  for  10  min.  Lysates  were 
normalized  for  protein  content  using  the  protein  assay  reagent  (500-0006,  Bio-Rad  Laboratories, 
USA). Equal amounts of denatured proteins were loaded and separated on a 10% SDS polyacrylamide 
gel, and were then transferred to a polyvinylene difluoride (PVDF) membrane. After blocking with 2% 
gelatin,  the  membrane  was  stained  with  specific  primary  antibodies  against  transferrin  receptor  
(13-6800 Zymed Laboratories, South San Francisco CA, USA) and actin, respectively, followed by 
secondary  antibody  IgG  conjugated  to  horseradish  peroxidase  in  TBS-T  buffer.  The  signals  were 
detected  using  the  ECL
TMPlus  Western  Blotting  Analysis  System  (Amersham  Pharmacia  Biotech, 
Piscataway, NJ, USA), followed by short exposures to Lumi-film Chemiluminescence Detection Film 
(Roche  Diagnostics  Corporation,  Indianapolis,  IN,  USA).  Band  intensities  were  quantified  by  the 
software PD Quest (BioRad Laboratories, Hercules, CA, USA) and normalized by β-actin [12]. 
3.7. Internalization of transferrin by Geoditin A-treated HT29 cells  
HT29 cells were pre-treated with serial concentrations of geoditin A for 24 h, depleted endogenous 
transferrin by incubating in plain DMEM containing 1% BSA for 1 h before transferrin uptake assay 
was performed for 1 h in DMEM containing 50 µ g/mL Alexa-594 transferrin. The cells were then 
washed two times with ice-cold PBS, fixed with 2% PFA for 20 min and then subjected to confocal 
fluorescence microscopy. Another portion of cells (20,000/group) treated the same way were subjected 
to flow cytometric measurement of transferrin uptake.  
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